{"entity":{"type":"insider","cik":"0001996353","url":"/insider/0001996353","json_url":"/insider/0001996353.json","name":"McNulty Brian Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":3,"first":"2023-12-27","last":"2024-08-30","span_basis":"filed_date"},"name_variants":[{"name":"McNulty Brian Patrick","source":"filing","n_filings":3,"first_seen":"2023-12-27","last_seen":"2024-08-30"}],"transactions":[{"id":2055887,"accession":"0001493152-24-034584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-034584","line_url":"/filing/0001493152-24-034584#line-1","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":392000.0,"total_display":"392,000.00","total_whole":"392,000","shares_owned_after":2540270.0,"shares_owned_after_display":"2,540,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-08-30","scope":"insider"},{"id":3015461,"accession":"0000897069-24-000395","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000897069-24-000395","line_url":"/filing/0000897069-24-000395","is_derivative":false,"issuer_cik":"0001971532","issuer_name":"Telomir Pharmaceuticals, Inc.","issuer_ticker":"TELO","issuer_name_source":null,"issuer_url":"/issuer/0001971532","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":138000.0,"shares_display":"138,000","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":966000.0,"total_display":"966,000.00","total_whole":"966,000","shares_owned_after":5455431.0,"shares_owned_after_display":"5,455,431","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-15","scope":"insider","n_lines":3},{"id":8740511,"accession":"0000897069-23-001850","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46005.0,"shares_display":"46,005","price_per_share":1.5541,"price_display":"1.55","price_state":"stated","total_value":71496.3705,"total_display":"71,496.37","total_whole":"71,496","shares_owned_after":2740270.0,"shares_owned_after_display":"2,740,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740506,"accession":"0000897069-23-001850","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19053.0,"shares_display":"19,053","price_per_share":1.6078,"price_display":"1.61","price_state":"stated","total_value":30633.4134,"total_display":"30,633.41","total_whole":"30,633","shares_owned_after":683002.0,"shares_owned_after_display":"683,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740502,"accession":"0000897069-23-001850","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33333.0,"shares_display":"33,333","price_per_share":1.8947,"price_display":"1.89","price_state":"stated","total_value":63156.0351,"total_display":"63,156.04","total_whole":"63,156","shares_owned_after":692529.0,"shares_owned_after_display":"692,529","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740498,"accession":"0000897069-23-001850","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27733.0,"shares_display":"27,733","price_per_share":2.949,"price_display":"2.95","price_state":"stated","total_value":81784.617,"total_display":"81,784.62","total_whole":"81,785","shares_owned_after":2789465.0,"shares_owned_after_display":"2,789,465","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740494,"accession":"0000897069-23-001850","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61331.0,"shares_display":"61,331","price_per_share":3.98,"price_display":"3.98","price_state":"stated","total_value":244097.38,"total_display":"244,097.38","total_whole":"244,097","shares_owned_after":723062.0,"shares_owned_after_display":"723,062","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740490,"accession":"0000897069-23-001850","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4842.0,"shares_display":"4,842","price_per_share":3.7738,"price_display":"3.77","price_state":"stated","total_value":18272.7396,"total_display":"18,272.74","total_whole":"18,273","shares_owned_after":2833997.0,"shares_owned_after_display":"2,833,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-30","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740486,"accession":"0000897069-23-001850","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7399.0,"shares_display":"7,399","price_per_share":3.9796,"price_display":"3.98","price_state":"stated","total_value":29445.0604,"total_display":"29,445.06","total_whole":"29,445","shares_owned_after":756149.0,"shares_owned_after_display":"756,149","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740482,"accession":"0000897069-23-001850","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":241.0,"shares_display":"241","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":964.0,"total_display":"964.00","total_whole":"964","shares_owned_after":2840117.0,"shares_owned_after_display":"2,840,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740478,"accession":"0000897069-23-001850","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6425.0,"shares_display":"6,425","price_per_share":4.0024,"price_display":"4.00","price_state":"stated","total_value":25715.42,"total_display":"25,715.42","total_whole":"25,715","shares_owned_after":2840238.0,"shares_owned_after_display":"2,840,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740472,"accession":"0000897069-23-001850","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":2843451.0,"shares_owned_after_display":"2,843,451","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-12-27","scope":"insider","n_lines":2},{"id":8740468,"accession":"0000897069-23-001850","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000897069-23-001850","line_url":"/filing/0000897069-23-001850","is_derivative":false,"issuer_cik":"0001904286","issuer_name":"MIRA PHARMACEUTICALS, INC.","issuer_ticker":"MIRA","issuer_name_source":null,"issuer_url":"/issuer/0001904286","owner_cik":null,"owner_name":"Bay Shore Trust; McNulty Brian Patrick","owner_display_name":"Bay Shore Trust","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26733.0,"shares_display":"26,733","price_per_share":5.0695,"price_display":"5.07","price_state":"stated","total_value":135522.9435,"total_display":"135,522.94","total_whole":"135,523","shares_owned_after":2845951.0,"shares_owned_after_display":"2,845,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-12-27","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001904286","name":"MIRA PHARMACEUTICALS, INC.","url":"/issuer/0001904286","role":"Ten percent owner","n_filings":2,"first_seen":"2023-12-27","last_seen":"2024-08-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001971532","name":"Telomir Pharmaceuticals, Inc.","url":"/issuer/0001971532","role":"Ten percent owner","n_filings":1,"first_seen":"2024-02-15","last_seen":"2024-02-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001996353","retrieved_at":"2026-08-23T21:23:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}